IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 241 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,216 | -41.4% | 276,300 | +8.2% | 0.00% | 0.0% |
| Q1 2024 | $3,783 | -44.4% | 255,353 | -69.5% | 0.00% | -50.0% |
| Q4 2023 | $6,799 | +97.1% | 836,175 | +10.3% | 0.00% | 0.0% |
| Q3 2023 | $3,449 | -7.5% | 757,951 | +43.1% | 0.00% | 0.0% |
| Q2 2023 | $3,730 | +46.3% | 529,592 | +27.0% | 0.00% | +100.0% |
| Q1 2023 | $2,550 | -36.8% | 417,160 | -33.9% | 0.00% | -50.0% |
| Q4 2022 | $4,033 | -99.9% | 630,950 | +61.5% | 0.00% | -50.0% |
| Q3 2022 | $3,742,000 | +681.2% | 390,606 | +799.7% | 0.00% | – |
| Q2 2022 | $479,000 | -60.8% | 43,415 | -40.7% | 0.00% | -100.0% |
| Q1 2022 | $1,221,000 | +435.5% | 73,264 | +515.5% | 0.00% | – |
| Q4 2021 | $228,000 | -70.0% | 11,904 | -61.5% | 0.00% | – |
| Q3 2021 | $761,000 | -67.6% | 30,890 | -65.8% | 0.00% | -100.0% |
| Q2 2021 | $2,350,000 | +8.5% | 90,263 | +32.0% | 0.00% | 0.0% |
| Q1 2021 | $2,166,000 | -29.9% | 68,394 | +2.7% | 0.00% | -50.0% |
| Q4 2020 | $3,090,000 | +59.2% | 66,573 | +12.9% | 0.00% | +100.0% |
| Q3 2020 | $1,941,000 | -63.2% | 58,956 | -69.4% | 0.00% | -75.0% |
| Q2 2020 | $5,281,000 | +44.8% | 192,379 | +57.9% | 0.00% | +33.3% |
| Q1 2020 | $3,648,000 | -38.3% | 121,816 | -43.0% | 0.00% | 0.0% |
| Q4 2019 | $5,915,000 | +207.9% | 213,681 | +102.5% | 0.00% | +200.0% |
| Q3 2019 | $1,921,000 | +4.5% | 105,512 | +40.8% | 0.00% | 0.0% |
| Q2 2019 | $1,838,000 | +244.2% | 74,934 | +33.7% | 0.00% | – |
| Q1 2019 | $534,000 | -0.9% | 56,028 | +17.1% | 0.00% | – |
| Q3 2018 | $539,000 | +222.8% | 47,860 | +267.8% | 0.00% | – |
| Q2 2018 | $167,000 | -42.6% | 13,014 | -24.6% | 0.00% | – |
| Q1 2018 | $291,000 | +1.7% | 17,261 | -51.8% | 0.00% | – |
| Q4 2017 | $286,000 | +1044.0% | 35,799 | +1006.3% | 0.00% | – |
| Q3 2017 | $25,000 | – | 3,236 | +7990.0% | 0.00% | – |
| Q2 2017 | $0 | – | 40 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 3,019,201 | $26,720,000 | 20.38% |
| Broadfin Capital, LLC | 5,951,153 | $52,668,000 | 6.92% |
| GREAT POINT PARTNERS LLC | 5,567,348 | $49,271,000 | 6.23% |
| Avoro Capital Advisors LLC | 10,261,039 | $90,810,000 | 5.43% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $19,367,000 | 5.00% |
| Prosight Management, LP | 1,062,500 | $9,403,000 | 4.85% |
| Perceptive Advisors | 12,241,111 | $108,333,000 | 4.12% |
| Ghost Tree Capital, LLC | 1,000,000 | $8,850,000 | 3.21% |
| QVT Financial LP | 1,021,361 | $8,696,000 | 2.84% |
| Vivo Capital, LLC | 1,600,000 | $14,160,000 | 1.81% |